Auflistung nach Titel
Anzeige der Publikationen 4536-4555 von 11406
-
2018-07-19ZeitschriftenartikelHepatitis C im Jahr 2017 Zur Situation bei wichtigen Infektionskrankheiten in DeutschlandAm 28. Juli 2018 findet der diesjährige Welt-Hepatitis-Tag unter dem Motto „Hepatitis: Findet die fehlenden Millionen!“ statt. Aus diesem Anlass widmen sich zwei Ausgaben des Epidemiologischen Bulletins der Hepatitis-Situation, ...
-
2014-07-28ZeitschriftenartikelHepatitis C Virus Infection Epidemiology among People Who Inject Drugs in Europe: A Systematic Review of Data for Scaling Up Treatment and Prevention Background: People who inject drugs (PWID) are a key population affected by hepatitis C virus (HCV). Treatment options are improving and may enhance prevention; however access for PWID may be poor. The availability in ...
-
2018-02-27ZeitschriftenartikelHepatitis C virus: Morphogenesis, infection and therapy Hepatitis C virus (HCV) is a major cause of liver diseases including liver cirrhosis and hepatocellular carcinoma. Approximately 3% of the world population is infected with HCV. Thus, HCV infection is considered a public ...
-
2014-09-01ZeitschriftenartikelHepatitis E in Deutschland – eine unterschätzte Infektionskrankheit Hintergrund: Mindestens 17 % der in Deutschland lebenden Bevölkerung haben eine Infektion mit dem Hepatitis-E-Virus (HEV) durchgemacht. Somit ist diese Infektion in Deutschland häufiger als bislang angenommen. Demgegenüber ...
-
2019-03-13ZeitschriftenartikelHepatitis E virus (HEV)—The Future Hepatitis (HEV) is widely distributed in pigs and is transmitted with increasing numbers to humans by contact with pigs, contaminated food and blood transfusion. The virus is mostly apathogenic in pigs but may enhance the ...
-
2015-10-22ZeitschriftenartikelHepatitis E virus antibody prevalence in hunters from a district in Central Germany, 2013: a cross-sectional study providing evidence for the benefit of protective gloves during disembowelling of wild boars Background: In Germany, 17 % of the general human population have antibodies to hepatitis E virus (HEV) (recomLine HEV-IgG/IgM immunoassay [Mikrogen GmbH]). Wild boars represent an animal reservoir for HEV genotype 3, ...
-
2017-06-29ZeitschriftenartikelHepatitis E virus infection in Europe: surveillance and descriptive epidemiology of confirmed cases, 2005 to 2015 Hepatitis E virus (HEV) is an under-recognised cause of acute hepatitis in high-income countries. The purpose of this study was to provide an overview of testing, diagnosis, surveillance activities, and data on confirmed ...
-
2021-04-29ZeitschriftenartikelHepatitis E virus infection in high-risk populations in Osun State, Nigeria Hepatitis E virus (HEV) infection is an emerging infection that is of major public health concern, especially in some vulnerable groups like immunosuppressed individuals, pregnant women and HBV-coinfected individuals. HEV ...
-
2016-08-06ZeitschriftenartikelHepatitis E Virus Mutations: Functional and Clinical Relevance Hepatitis E virus (HEV) infection is a major cause of acute hepatitis and affects more than 20 million individuals, with three million symptomatic cases and 56,000 recognized HEV-related deaths worldwide. HEV is endemic ...
-
2012-10-01ZeitschriftenartikelHepatitis E Virus Seroprevalence among Adults, Germany We assessed hepatitis E virus (HEV) antibody seroprevalence in a sample of the adult population in Germany. Overall HEV IgG prevalence was 16.8% (95% CI 15.6%–17.9%) and increased with age, leveling off at >60 years ...
-
2015-11-11ZeitschriftenartikelHepatitis E Virus Superinfection and Clinical Progression in Hepatitis B Patients Hepatitis E virus (HEV) infection may cause acute hepatitis and lead to hepatic failure in developing and developed countries. We studied HEV seroprevalences in patients with hepatitis B virus (HBV) infection to understand ...
-
2021-05-07ZeitschriftenartikelHepatitis E: An update on One Health and clinical medicine The hepatitis E virus (HEV) is one of the main causes of acute hepatitis and the de facto global burden is underestimated. HEV-related clinical complications are often undetected and are not considered in the differential ...
-
2001-08-14Berichte und sonstige TexteHepatitis-A-Virus (HAV) - Stellungnahme des Arbeitskreises Blut
-
2000-03-14Berichte und sonstige TexteHepatitis-B-Virus (HBV) - Stellungnahme des Arbeitskreises Blut
-
2021-12-27ZeitschriftenartikelHepatitis-B-Virus-Infektionen und impfinduzierte Immunität: die Rolle von soziodemografischen Determinanten Hintergrund und Ziel: Trotz niedriger Prävalenz der Hepatitis-B-Virus-(HBV-)Infektion in Deutschland ist es wichtig, vulnerable Gruppen und Ansatzpunkte für die Prävention zu identifizieren. In ersten Analysen der „Studie ...
-
2019-07-25ZeitschriftenartikelHepatitis-C-Meldedaten nach IfSG, 2016 – 2018: Auswirkungen der Änderungen von Falldefinition und Meldepflicht Im Zeitraum 2016–2018 ist die Inzidenz übermittelter Hepatitis-C-Virus-Infektionen angestiegen. Wie das Epidemiologische Bulletin 30/2019 ausführt, wurde nach einem zuvor (bis 2016) zu beobachtenden Abfall der Meldeinzidenz ...
-
2003-08-12Berichte und sonstige TexteHepatitis-C-Virus (HCV) - Stellungnahme des Arbeitskreises Blut
-
2015-01-22ZeitschriftenartikelHepatitis-E-Virus
-
2008-01-08Berichte und sonstige TexteHepatitis-E-Virus - Stellungnahme des Arbeitskreises Blut
-
2012-12-01ZeitschriftenartikelHER2/neu DNA vaccination by intradermal gene delivery in a mouse tumor model Gene gun is superior to jet injector in inducing CTL responses and protective immunityDNA vaccines are potential tools for the induction of immune responses against both infectious disease and cancer. The dermal application of DNA vaccines is of particular interest since the epidermal and dermal layers of ...